Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gullestad

Showing results (241-250 of 382) with videos related to

Pageof 39
Sort By:
Circulation. Heart Failure|December 12, 2012
Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Erik Tandberg Askevold, Ståle Nymo, Thor Ueland, et al.
JACC. Heart Failure|March 14, 2014
Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure)Ana Cristina Perez, Pardeep S Jhund, David J Stott, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 31, 2011
QT response after a test dose and during maintenance therapy with AZD1305 in patients with atrial fibrillation: a double-blind, randomized, placebo-controlled trialKenneth Egstrup, Lennart Bergfeldt, Tibor Duris, et al.
European Journal of Heart Failure|July 2, 2009
Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failureJohn K Kjekshus, Christian Torp-Pedersen, Lars Gullestad, et al.
Plos One|March 4, 2014
The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trialKaspar Broch, Erik T Askevold, Erik Gjertsen, et al.
Atherosclerosis|April 16, 2014
Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13Bente Halvorsen, Linda M Smedbakken, Annika E Michelsen, et al.
European Journal of Heart Failure|March 15, 2013
CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trialsThor Ueland, Ståle H Nymo, Roberto Latini, et al.
ESC Heart Failure|February 15, 2020
Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipientsNiklas Bergh, Einar Gude, Sven-Erik Bartfay, et al.
Journal of Cardiac Failure|August 2, 2015
Altered Levels of Fatty Acids and Inflammatory and Metabolic Mediators in Epicardial Adipose Tissue in Patients With Systolic Heart FailureLinn E Fosshaug, Christen P Dahl, Ivar Risnes, et al.
Heart (British Cardiac Society)|July 18, 2014
Familial globotriaosylceramide-associated cardiomyopathy mimicking Fabry diseaseTurid Apelland, Einar Gude, Erik H Strøm, et al.
Pageof 39

Showing results (241-250 of 382) with videos related to

Sort By:
Pageof 39
Circulation. Heart Failure|December 12, 2012
Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Erik Tandberg Askevold, Ståle Nymo, Thor Ueland, et al.
JACC. Heart Failure|March 14, 2014
Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure)Ana Cristina Perez, Pardeep S Jhund, David J Stott, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 31, 2011
QT response after a test dose and during maintenance therapy with AZD1305 in patients with atrial fibrillation: a double-blind, randomized, placebo-controlled trialKenneth Egstrup, Lennart Bergfeldt, Tibor Duris, et al.
European Journal of Heart Failure|July 2, 2009
Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failureJohn K Kjekshus, Christian Torp-Pedersen, Lars Gullestad, et al.
Plos One|March 4, 2014
The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trialKaspar Broch, Erik T Askevold, Erik Gjertsen, et al.
Atherosclerosis|April 16, 2014
Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13Bente Halvorsen, Linda M Smedbakken, Annika E Michelsen, et al.
European Journal of Heart Failure|March 15, 2013
CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trialsThor Ueland, Ståle H Nymo, Roberto Latini, et al.
ESC Heart Failure|February 15, 2020
Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipientsNiklas Bergh, Einar Gude, Sven-Erik Bartfay, et al.
Journal of Cardiac Failure|August 2, 2015
Altered Levels of Fatty Acids and Inflammatory and Metabolic Mediators in Epicardial Adipose Tissue in Patients With Systolic Heart FailureLinn E Fosshaug, Christen P Dahl, Ivar Risnes, et al.
Heart (British Cardiac Society)|July 18, 2014
Familial globotriaosylceramide-associated cardiomyopathy mimicking Fabry diseaseTurid Apelland, Einar Gude, Erik H Strøm, et al.
Pageof 39